Medication-Related Issues in Ovarian Cancer Patients
Not Applicable
- Conditions
- Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
- Registration Number
- CTRI/2021/08/035818
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Hospitalized patients above 18 years of age
Diagnosed with ovarian cancer and receiving chemotherapy and willing to participate in the study
Exclusion Criteria
Patients who are having psychiatric and other terminal illnesses
Pregnant and breastfeeding patients
Patients diagnosed with more than two primary cancer
Patients having other severe comorbidities like; Uncontrolled DM, uncontrolled HTN, and other severe cardiac co-morbidities.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development of the prediction model for the detection of DRPsTimepoint: The predictors will be developed with in the 12 to 18 months
- Secondary Outcome Measures
Name Time Method Clinical Outcomes and Economic outcomes after months <br/ ><br>Health-Related Quality of life <br/ ><br>Timepoint: The patients will be in follow-up from the day of hospital admission to discharge day.